N
Nathan M. Mollberg
Researcher at University of Illinois at Urbana–Champaign
Publications - 35
Citations - 1717
Nathan M. Mollberg is an academic researcher from University of Illinois at Urbana–Champaign. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 14, co-authored 33 publications receiving 1546 citations. Previous affiliations of Nathan M. Mollberg include University of Washington & University of Chicago.
Papers
More filters
Journal ArticleDOI
Arterial Resection During Pancreatectomy for Pancreatic Cancer: A Systematic Review and Meta-Analysis
Nathan M. Mollberg,Nuh N. Rahbari,Moritz Koch,Werner Hartwig,Yumiko Hoeger,Markus W. Büchler,Jürgen Weitz +6 more
TL;DR: AR in patients undergoing pancreatectomy for pancreatic cancer is associated with a poor short and long-term outcome, and pancakes with AR may be justified in highly selected patients owing to the potential survival benefit compared with patients without resection.
Journal ArticleDOI
Hepatocellular carcinoma: current management and perspectives for the future.
Nuh N. Rahbari,Arianeb Mehrabi,Nathan M. Mollberg,Sascha A. Müller,Moritz Koch,Markus W. Büchler,Jürgen Weitz +6 more
TL;DR: Recent developments in the surgical and medical therapy have significantly improved outcome of patients with operable and advanced HCC, and a multidisciplinary approach seems essential to further improve patients' prognosis.
Journal ArticleDOI
Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer
Nuh N. Rahbari,Maximilian Aigner,Kristian Thorlund,Nathan M. Mollberg,Edith Motschall,Katrin Jensen,Markus K. Diener,Markus W. Büchler,Moritz Koch,Jürgen Weitz +9 more
TL;DR: In this article, the authors performed a meta-analysis of available studies to assess whether the detection of tumor cells in the blood and bone marrow (BM) of patients diagnosed with primary colorectal cancer can be used as a prognostic factor.
Journal ArticleDOI
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse.
Christoph Kahlert,H Weber,Carolin Mogler,Frank Bergmann,Peter Schirmacher,Hannes Kenngott,U Matterne,Nathan M. Mollberg,Nuh N. Rahbari,Ulf Hinz,Moritz Koch,Maximilian Aigner,Juergen Weitz +12 more
TL;DR: It is shown that in normal pancreatic tissue, ALCAM is predominantly expressed at the cellular membrane, whereas in pancreatic tumour cells, it is mainly localised in the cytoplasm, and univariate and multivariate analyses show that increased expression of A LCAM is an adverse prognostic factor for recurrence-free and overall survival.
Journal ArticleDOI
Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: An analysis of surgical morbidity and mortality
Bryan M. Burt,Robert B. Cameron,Nathan M. Mollberg,Andrzej S. Kosinski,Paul H. Schipper,Joseph B. Shrager,Wickii T. Vigneswaran +6 more
TL;DR: Extrapleural pneumonectomy is associated with greater morbidity and mortality compared with pleurectomy/decortication when performed by participating surgeons of the Society ofThoracic Surgeons-General Thoracic Database.